VaxyGen, GSURF sign exclusive licence, collaboration deal.
M2 PHARMA-October 20, 2011-VaxyGen, GSURF sign exclusive licence, collaboration deal(C)2011 M2 COMMUNICATIONS
20 October 2011 - US VaxyGen Manufacturing Services LLC, a unit of VaxyGen Holdings LLC, said it had signed an exclusive licence and collaboration agreement with Georgia State University Research Foundation (GSURF).
The agreement provides VaxyGen with a licence to a patent for producing and purifying proteins in development as biopharmaceutical products and vaccines.
Under the collaborative contract, VaxyGen will be responsible for marketing the expertise and know-how resident in the Georgia State University Biological Process Development and Research Laboratory.
VaxyGen Manufacturing Services offers custom contract services in support of biological process optimisation, scale-up and the development of manufacturing processes relative to biopharmaceutical and vaccine products.
((Comments on this story may be sent to firstname.lastname@example.org))